This inventor holds 1 USPTO granted patent. Top assignee: Basf K&f. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Edward B Kristen: Innovator in Cardiac Treatment
Introduction
Edward B Kristen is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiac arrhythmia. His innovative approach combines established medications to enhance their effectiveness.
Latest Patents
Kristen holds a patent for a long-lasting composition of propafenone and quinidine for the treatment of cardiac arrhythmia. This pharmaceutical composition comprises an effective amount of propafenone in combination with a subtherapeutic amount of quinidine. The unique combination allows quinidine to potentiate the elimination half-life of propafenone. The invention also includes a method for treating patients with cardiac arrhythmia by administering this pharmaceutical composition. He has 1 patent to his name.
Career Highlights
Edward B Kristen is associated with BASF K&F, where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions for complex medical conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Kristen collaborates with Juan R Guerrero, working together to advance their research and development efforts in the pharmaceutical industry.
Conclusion
Edward B Kristen's contributions to cardiac treatment through his innovative patent demonstrate his dedication to enhancing medical therapies. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile